drugset / Trial / NCT00286364

Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial

NCT00286364

Phase 4 Completed Rigshospitalet, Denmark
RandomizedParallel-groupOpen-labelTreatment

Summary

We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement compared to standard short antagonist protocol

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified 1 mg
Subject Cetrorelix Other / unclassified 3 mg
Subject human chorionic gonadotropin Protein / enzyme biologic 1250 iu

Indications